SFDA official: Nader program streamlines access to rare disease treatments
The Nader program offers regulatory incentives to accelerate access to rare disease therapies, supporting researchers and pharmaceutical developers, an SFDA official said.
We haven't written up this one. Ajel English has the full story — the link below goes straight to it.